Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 ·Status: UNKNOWN ·Phase: PHASE3

A Trial of Remdesivir in Adults With Severe COVID-19

NCT04257656 ·Status: TERMINATED ·Phase: PHASE3

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541 ·Status: COMPLETED ·Phase: PHASE3

JT001 (VV116) for the Early Treatment of COVID-19

NCT05242042 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19

NCT04527471 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

NCT05506176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05620160 ·Status: COMPLETED ·Phase: PHASE3

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

NCT05387369 ·Status: RECRUITING

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

NCT05157269 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

NCT05341609 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects

NCT04880642 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

NCT04871646 ·Status: UNKNOWN ·Phase: PHASE3

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

NCT04252664 ·Status: SUSPENDED ·Phase: PHASE3

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

NCT05305547 ·Status: COMPLETED ·Phase: PHASE3

Study of HS-10517 in Chinese Adult Participants

NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT06667700 ·Status: RECRUITING ·Phase: PHASE3

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

NCT05459532 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

NCT04676867 ·Status: COMPLETED ·Phase: PHASE2

MP1032 Treatment in Patients With Moderate to Severe COVID-19

NCT04932941 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

NCT04547140 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

NCT04880109 ·Status: TERMINATED ·Phase: PHASE2